BiomEdit Launches Final Trial for Non-Antibiotic Poultry Solution as USDA Review Approaches BiomEdit has commenced its pivotal field safety trial for BE-101, a non-antibiotic poultry biologic, advancing toward USDA licensure in 2026.

BiomEdit Launches Final Trial for Non-Antibiotic Poultry Solution as USDA Review Approaches #United_States #Greenfield #BiomEdit #BE-101 #Poultry_Health

BiomEdit Receives USDA FONSI for Groundbreaking Poultry Biologic, Advancing Toward Field Trials BiomEdit has announced it received a significant FONSI from the USDA for its poultry biologic, paving the way for crucial field trials aimed at preventing necrotic enteritis.

BiomEdit Receives USDA FONSI for Groundbreaking Poultry Biologic, Advancing Toward Field Trials #United_States #Greenfield #USDA #BiomEdit #BE-101

BiomEdit Secures $2 Million from Bezos Earth Fund for AI-Driven Methane Reduction in Cattle BiomEdit has received nearly $2 million from the Bezos Earth Fund to develop AI models that tackle methane emissions in cattle, enhancing productivity.

BiomEdit Secures $2 Million from Bezos Earth Fund for AI-Driven Methane Reduction in Cattle #USA #Greenfield #AI_Model #BiomEdit #methane-reduction